More than five stentriever passes: real benefit or futile recanalization?

Background and aims Clot extraction is associated with favorable outcome in patients with large vessel occlusions (LVO) undergoing endovascular thrombectomy (EVT). However, whether revascularization becomes futile or harmful with an increasing number of passes remains unknown. Methods We performed a...

Ausführliche Beschreibung

Gespeichert in:
Bibliographische Detailangaben
Veröffentlicht in:Neuroradiology 2020-10, Vol.62 (10), p.1335-1340
Hauptverfasser: Filioglo, A., Cohen, J. E., Honig, A., Simaan, N., Gomori, J. M., Leker, Ronen R.
Format: Artikel
Sprache:eng
Schlagworte:
Online-Zugang:Volltext
Tags: Tag hinzufügen
Keine Tags, Fügen Sie den ersten Tag hinzu!
container_end_page 1340
container_issue 10
container_start_page 1335
container_title Neuroradiology
container_volume 62
creator Filioglo, A.
Cohen, J. E.
Honig, A.
Simaan, N.
Gomori, J. M.
Leker, Ronen R.
description Background and aims Clot extraction is associated with favorable outcome in patients with large vessel occlusions (LVO) undergoing endovascular thrombectomy (EVT). However, whether revascularization becomes futile or harmful with an increasing number of passes remains unknown. Methods We performed a retrospective analysis of 271 consecutive patients with LVO who underwent stentriever-based EVT as the primary recanalization strategy. Primary outcomes including favorable recanalization, survival, and favorable functional outcomes were compared according to a dichotomized number of stentriever passes utilized with a cutoff of 4. Results In the entire cohort, 234 (86%) patients reached favorable recanalization and 46 (17%) patients had ≥ 5 passes (range 5–40). Patients that had ≤ 4 passes had significantly higher rates of favorable recanalization and favorable outcomes and a trend towards lower mortality rates compared with those that had ≥ 5 stentriever passes (92% vs. 61%; p < 0.001, 52% vs. 30%; p = 0.009 and 12% vs. 22%, p = 0.098). Among patients that received ≥ 5 stentriever passes, 30% reached favorable outcomes. Patients who achieved recanalization after ≥ 5 passes had higher rates of favorable outcome in comparison with those who did not ( p = 0.009). Among patients that had ≥ 5 stentriever passes favorable recanalization (OR 97.3, 95%CI 2.8–3399.3) and admission NIHSS (OR 0.77, 95%CI 0.60–0.99) remained independent predictors of favorable outcome, whereas the number of passes did not. Conclusions A substantial proportion of patients reach favorable outcomes even when ≥ 5 stentriever passes are performed. Treatment choices should be individualized based on personal preferences and expertise as well as on patient and clot-specific characteristics.
doi_str_mv 10.1007/s00234-020-02469-x
format Article
fullrecord <record><control><sourceid>proquest_cross</sourceid><recordid>TN_cdi_proquest_miscellaneous_2415291593</recordid><sourceformat>XML</sourceformat><sourcesystem>PC</sourcesystem><sourcerecordid>2415291593</sourcerecordid><originalsourceid>FETCH-LOGICAL-c352t-50f32db25c494a9b191f1dcd68118f688eddc35de1ce8350c37680f91a7773e43</originalsourceid><addsrcrecordid>eNp9kE1LAzEQhoMoWKt_wFPAi5fVycd-xItI8aNQ8aLnkGYnumW7W5Nsqf56UysIHjwMAzPPOwwPIacMLhhAeRkAuJAZcEglC5Vt9siIScEzpjjsk1HaV5lQEg7JUQgLABClKEdk-th7pPHNdNQ1a6QhYhd9g2v0dGVCwHBFPZqWzrFD10Tae-qG2LSYxtZ0pm0-TWz67vqYHDjTBjz56WPycnf7PHnIZk_308nNLLMi5zHLwQlez3lupZJGzZlijtW2LirGKldUFdZ1ImtkFiuRgxVlUYFTzJRlKVCKMTnf3V35_n3AEPWyCRbb1nTYD0FzyXKuWK5EQs_-oIt-8OnnLSWhzJWSRaL4jrK-D8Gj0yvfLI3_0Az01q7e2dXJrv62qzcpJHahkODuFf3v6X9SXw_FfLU</addsrcrecordid><sourcetype>Aggregation Database</sourcetype><iscdi>true</iscdi><recordtype>article</recordtype><pqid>2440759946</pqid></control><display><type>article</type><title>More than five stentriever passes: real benefit or futile recanalization?</title><source>SpringerLink Journals - AutoHoldings</source><creator>Filioglo, A. ; Cohen, J. E. ; Honig, A. ; Simaan, N. ; Gomori, J. M. ; Leker, Ronen R.</creator><creatorcontrib>Filioglo, A. ; Cohen, J. E. ; Honig, A. ; Simaan, N. ; Gomori, J. M. ; Leker, Ronen R.</creatorcontrib><description>Background and aims Clot extraction is associated with favorable outcome in patients with large vessel occlusions (LVO) undergoing endovascular thrombectomy (EVT). However, whether revascularization becomes futile or harmful with an increasing number of passes remains unknown. Methods We performed a retrospective analysis of 271 consecutive patients with LVO who underwent stentriever-based EVT as the primary recanalization strategy. Primary outcomes including favorable recanalization, survival, and favorable functional outcomes were compared according to a dichotomized number of stentriever passes utilized with a cutoff of 4. Results In the entire cohort, 234 (86%) patients reached favorable recanalization and 46 (17%) patients had ≥ 5 passes (range 5–40). Patients that had ≤ 4 passes had significantly higher rates of favorable recanalization and favorable outcomes and a trend towards lower mortality rates compared with those that had ≥ 5 stentriever passes (92% vs. 61%; p &lt; 0.001, 52% vs. 30%; p = 0.009 and 12% vs. 22%, p = 0.098). Among patients that received ≥ 5 stentriever passes, 30% reached favorable outcomes. Patients who achieved recanalization after ≥ 5 passes had higher rates of favorable outcome in comparison with those who did not ( p = 0.009). Among patients that had ≥ 5 stentriever passes favorable recanalization (OR 97.3, 95%CI 2.8–3399.3) and admission NIHSS (OR 0.77, 95%CI 0.60–0.99) remained independent predictors of favorable outcome, whereas the number of passes did not. Conclusions A substantial proportion of patients reach favorable outcomes even when ≥ 5 stentriever passes are performed. Treatment choices should be individualized based on personal preferences and expertise as well as on patient and clot-specific characteristics.</description><identifier>ISSN: 0028-3940</identifier><identifier>EISSN: 1432-1920</identifier><identifier>DOI: 10.1007/s00234-020-02469-x</identifier><language>eng</language><publisher>Berlin/Heidelberg: Springer Berlin Heidelberg</publisher><subject>Blood vessels ; Cardiovascular system ; Imaging ; Interventional Neuroradiology ; Medicine ; Medicine &amp; Public Health ; Neurology ; Neuroradiology ; Neurosciences ; Neurosurgery ; Radiology</subject><ispartof>Neuroradiology, 2020-10, Vol.62 (10), p.1335-1340</ispartof><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020</rights><rights>Springer-Verlag GmbH Germany, part of Springer Nature 2020.</rights><lds50>peer_reviewed</lds50><woscitedreferencessubscribed>false</woscitedreferencessubscribed><citedby>FETCH-LOGICAL-c352t-50f32db25c494a9b191f1dcd68118f688eddc35de1ce8350c37680f91a7773e43</citedby><cites>FETCH-LOGICAL-c352t-50f32db25c494a9b191f1dcd68118f688eddc35de1ce8350c37680f91a7773e43</cites><orcidid>0000-0003-4794-0334</orcidid></display><links><openurl>$$Topenurl_article</openurl><openurlfulltext>$$Topenurlfull_article</openurlfulltext><thumbnail>$$Tsyndetics_thumb_exl</thumbnail><linktopdf>$$Uhttps://link.springer.com/content/pdf/10.1007/s00234-020-02469-x$$EPDF$$P50$$Gspringer$$H</linktopdf><linktohtml>$$Uhttps://link.springer.com/10.1007/s00234-020-02469-x$$EHTML$$P50$$Gspringer$$H</linktohtml><link.rule.ids>314,780,784,27922,27923,41486,42555,51317</link.rule.ids></links><search><creatorcontrib>Filioglo, A.</creatorcontrib><creatorcontrib>Cohen, J. E.</creatorcontrib><creatorcontrib>Honig, A.</creatorcontrib><creatorcontrib>Simaan, N.</creatorcontrib><creatorcontrib>Gomori, J. M.</creatorcontrib><creatorcontrib>Leker, Ronen R.</creatorcontrib><title>More than five stentriever passes: real benefit or futile recanalization?</title><title>Neuroradiology</title><addtitle>Neuroradiology</addtitle><description>Background and aims Clot extraction is associated with favorable outcome in patients with large vessel occlusions (LVO) undergoing endovascular thrombectomy (EVT). However, whether revascularization becomes futile or harmful with an increasing number of passes remains unknown. Methods We performed a retrospective analysis of 271 consecutive patients with LVO who underwent stentriever-based EVT as the primary recanalization strategy. Primary outcomes including favorable recanalization, survival, and favorable functional outcomes were compared according to a dichotomized number of stentriever passes utilized with a cutoff of 4. Results In the entire cohort, 234 (86%) patients reached favorable recanalization and 46 (17%) patients had ≥ 5 passes (range 5–40). Patients that had ≤ 4 passes had significantly higher rates of favorable recanalization and favorable outcomes and a trend towards lower mortality rates compared with those that had ≥ 5 stentriever passes (92% vs. 61%; p &lt; 0.001, 52% vs. 30%; p = 0.009 and 12% vs. 22%, p = 0.098). Among patients that received ≥ 5 stentriever passes, 30% reached favorable outcomes. Patients who achieved recanalization after ≥ 5 passes had higher rates of favorable outcome in comparison with those who did not ( p = 0.009). Among patients that had ≥ 5 stentriever passes favorable recanalization (OR 97.3, 95%CI 2.8–3399.3) and admission NIHSS (OR 0.77, 95%CI 0.60–0.99) remained independent predictors of favorable outcome, whereas the number of passes did not. Conclusions A substantial proportion of patients reach favorable outcomes even when ≥ 5 stentriever passes are performed. Treatment choices should be individualized based on personal preferences and expertise as well as on patient and clot-specific characteristics.</description><subject>Blood vessels</subject><subject>Cardiovascular system</subject><subject>Imaging</subject><subject>Interventional Neuroradiology</subject><subject>Medicine</subject><subject>Medicine &amp; Public Health</subject><subject>Neurology</subject><subject>Neuroradiology</subject><subject>Neurosciences</subject><subject>Neurosurgery</subject><subject>Radiology</subject><issn>0028-3940</issn><issn>1432-1920</issn><fulltext>true</fulltext><rsrctype>article</rsrctype><creationdate>2020</creationdate><recordtype>article</recordtype><sourceid>8G5</sourceid><sourceid>ABUWG</sourceid><sourceid>AFKRA</sourceid><sourceid>AZQEC</sourceid><sourceid>BENPR</sourceid><sourceid>CCPQU</sourceid><sourceid>DWQXO</sourceid><sourceid>GNUQQ</sourceid><sourceid>GUQSH</sourceid><sourceid>M2O</sourceid><recordid>eNp9kE1LAzEQhoMoWKt_wFPAi5fVycd-xItI8aNQ8aLnkGYnumW7W5Nsqf56UysIHjwMAzPPOwwPIacMLhhAeRkAuJAZcEglC5Vt9siIScEzpjjsk1HaV5lQEg7JUQgLABClKEdk-th7pPHNdNQ1a6QhYhd9g2v0dGVCwHBFPZqWzrFD10Tae-qG2LSYxtZ0pm0-TWz67vqYHDjTBjz56WPycnf7PHnIZk_308nNLLMi5zHLwQlez3lupZJGzZlijtW2LirGKldUFdZ1ImtkFiuRgxVlUYFTzJRlKVCKMTnf3V35_n3AEPWyCRbb1nTYD0FzyXKuWK5EQs_-oIt-8OnnLSWhzJWSRaL4jrK-D8Gj0yvfLI3_0Az01q7e2dXJrv62qzcpJHahkODuFf3v6X9SXw_FfLU</recordid><startdate>20201001</startdate><enddate>20201001</enddate><creator>Filioglo, A.</creator><creator>Cohen, J. E.</creator><creator>Honig, A.</creator><creator>Simaan, N.</creator><creator>Gomori, J. M.</creator><creator>Leker, Ronen R.</creator><general>Springer Berlin Heidelberg</general><general>Springer Nature B.V</general><scope>AAYXX</scope><scope>CITATION</scope><scope>3V.</scope><scope>7QO</scope><scope>7RV</scope><scope>7TK</scope><scope>7U7</scope><scope>7X7</scope><scope>7XB</scope><scope>88E</scope><scope>8AO</scope><scope>8FD</scope><scope>8FE</scope><scope>8FG</scope><scope>8FH</scope><scope>8FI</scope><scope>8FJ</scope><scope>8FK</scope><scope>8G5</scope><scope>ABUWG</scope><scope>AFKRA</scope><scope>ARAPS</scope><scope>AZQEC</scope><scope>BBNVY</scope><scope>BENPR</scope><scope>BGLVJ</scope><scope>BHPHI</scope><scope>C1K</scope><scope>CCPQU</scope><scope>DWQXO</scope><scope>FR3</scope><scope>FYUFA</scope><scope>GHDGH</scope><scope>GNUQQ</scope><scope>GUQSH</scope><scope>HCIFZ</scope><scope>K9.</scope><scope>KB0</scope><scope>LK8</scope><scope>M0S</scope><scope>M1P</scope><scope>M2O</scope><scope>M7P</scope><scope>MBDVC</scope><scope>NAPCQ</scope><scope>P5Z</scope><scope>P62</scope><scope>P64</scope><scope>PQEST</scope><scope>PQQKQ</scope><scope>PQUKI</scope><scope>PRINS</scope><scope>Q9U</scope><scope>7X8</scope><orcidid>https://orcid.org/0000-0003-4794-0334</orcidid></search><sort><creationdate>20201001</creationdate><title>More than five stentriever passes: real benefit or futile recanalization?</title><author>Filioglo, A. ; Cohen, J. E. ; Honig, A. ; Simaan, N. ; Gomori, J. M. ; Leker, Ronen R.</author></sort><facets><frbrtype>5</frbrtype><frbrgroupid>cdi_FETCH-LOGICAL-c352t-50f32db25c494a9b191f1dcd68118f688eddc35de1ce8350c37680f91a7773e43</frbrgroupid><rsrctype>articles</rsrctype><prefilter>articles</prefilter><language>eng</language><creationdate>2020</creationdate><topic>Blood vessels</topic><topic>Cardiovascular system</topic><topic>Imaging</topic><topic>Interventional Neuroradiology</topic><topic>Medicine</topic><topic>Medicine &amp; Public Health</topic><topic>Neurology</topic><topic>Neuroradiology</topic><topic>Neurosciences</topic><topic>Neurosurgery</topic><topic>Radiology</topic><toplevel>peer_reviewed</toplevel><toplevel>online_resources</toplevel><creatorcontrib>Filioglo, A.</creatorcontrib><creatorcontrib>Cohen, J. E.</creatorcontrib><creatorcontrib>Honig, A.</creatorcontrib><creatorcontrib>Simaan, N.</creatorcontrib><creatorcontrib>Gomori, J. M.</creatorcontrib><creatorcontrib>Leker, Ronen R.</creatorcontrib><collection>CrossRef</collection><collection>ProQuest Central (Corporate)</collection><collection>Biotechnology Research Abstracts</collection><collection>Nursing &amp; Allied Health Database</collection><collection>Neurosciences Abstracts</collection><collection>Toxicology Abstracts</collection><collection>Health &amp; Medical Collection</collection><collection>ProQuest Central (purchase pre-March 2016)</collection><collection>Medical Database (Alumni Edition)</collection><collection>ProQuest Pharma Collection</collection><collection>Technology Research Database</collection><collection>ProQuest SciTech Collection</collection><collection>ProQuest Technology Collection</collection><collection>ProQuest Natural Science Collection</collection><collection>Hospital Premium Collection</collection><collection>Hospital Premium Collection (Alumni Edition)</collection><collection>ProQuest Central (Alumni) (purchase pre-March 2016)</collection><collection>Research Library (Alumni Edition)</collection><collection>ProQuest Central (Alumni Edition)</collection><collection>ProQuest Central UK/Ireland</collection><collection>Advanced Technologies &amp; Aerospace Collection</collection><collection>ProQuest Central Essentials</collection><collection>Biological Science Collection</collection><collection>ProQuest Central</collection><collection>Technology Collection (ProQuest)</collection><collection>Natural Science Collection (ProQuest)</collection><collection>Environmental Sciences and Pollution Management</collection><collection>ProQuest One Community College</collection><collection>ProQuest Central Korea</collection><collection>Engineering Research Database</collection><collection>Health Research Premium Collection</collection><collection>Health Research Premium Collection (Alumni)</collection><collection>ProQuest Central Student</collection><collection>Research Library Prep</collection><collection>SciTech Premium Collection</collection><collection>ProQuest Health &amp; Medical Complete (Alumni)</collection><collection>Nursing &amp; Allied Health Database (Alumni Edition)</collection><collection>ProQuest Biological Science Collection</collection><collection>Health &amp; Medical Collection (Alumni Edition)</collection><collection>Medical Database</collection><collection>Research Library</collection><collection>Biological Science Database</collection><collection>Research Library (Corporate)</collection><collection>Nursing &amp; Allied Health Premium</collection><collection>Advanced Technologies &amp; Aerospace Database</collection><collection>ProQuest Advanced Technologies &amp; Aerospace Collection</collection><collection>Biotechnology and BioEngineering Abstracts</collection><collection>ProQuest One Academic Eastern Edition (DO NOT USE)</collection><collection>ProQuest One Academic</collection><collection>ProQuest One Academic UKI Edition</collection><collection>ProQuest Central China</collection><collection>ProQuest Central Basic</collection><collection>MEDLINE - Academic</collection><jtitle>Neuroradiology</jtitle></facets><delivery><delcategory>Remote Search Resource</delcategory><fulltext>fulltext</fulltext></delivery><addata><au>Filioglo, A.</au><au>Cohen, J. E.</au><au>Honig, A.</au><au>Simaan, N.</au><au>Gomori, J. M.</au><au>Leker, Ronen R.</au><format>journal</format><genre>article</genre><ristype>JOUR</ristype><atitle>More than five stentriever passes: real benefit or futile recanalization?</atitle><jtitle>Neuroradiology</jtitle><stitle>Neuroradiology</stitle><date>2020-10-01</date><risdate>2020</risdate><volume>62</volume><issue>10</issue><spage>1335</spage><epage>1340</epage><pages>1335-1340</pages><issn>0028-3940</issn><eissn>1432-1920</eissn><abstract>Background and aims Clot extraction is associated with favorable outcome in patients with large vessel occlusions (LVO) undergoing endovascular thrombectomy (EVT). However, whether revascularization becomes futile or harmful with an increasing number of passes remains unknown. Methods We performed a retrospective analysis of 271 consecutive patients with LVO who underwent stentriever-based EVT as the primary recanalization strategy. Primary outcomes including favorable recanalization, survival, and favorable functional outcomes were compared according to a dichotomized number of stentriever passes utilized with a cutoff of 4. Results In the entire cohort, 234 (86%) patients reached favorable recanalization and 46 (17%) patients had ≥ 5 passes (range 5–40). Patients that had ≤ 4 passes had significantly higher rates of favorable recanalization and favorable outcomes and a trend towards lower mortality rates compared with those that had ≥ 5 stentriever passes (92% vs. 61%; p &lt; 0.001, 52% vs. 30%; p = 0.009 and 12% vs. 22%, p = 0.098). Among patients that received ≥ 5 stentriever passes, 30% reached favorable outcomes. Patients who achieved recanalization after ≥ 5 passes had higher rates of favorable outcome in comparison with those who did not ( p = 0.009). Among patients that had ≥ 5 stentriever passes favorable recanalization (OR 97.3, 95%CI 2.8–3399.3) and admission NIHSS (OR 0.77, 95%CI 0.60–0.99) remained independent predictors of favorable outcome, whereas the number of passes did not. Conclusions A substantial proportion of patients reach favorable outcomes even when ≥ 5 stentriever passes are performed. Treatment choices should be individualized based on personal preferences and expertise as well as on patient and clot-specific characteristics.</abstract><cop>Berlin/Heidelberg</cop><pub>Springer Berlin Heidelberg</pub><doi>10.1007/s00234-020-02469-x</doi><tpages>6</tpages><orcidid>https://orcid.org/0000-0003-4794-0334</orcidid></addata></record>
fulltext fulltext
identifier ISSN: 0028-3940
ispartof Neuroradiology, 2020-10, Vol.62 (10), p.1335-1340
issn 0028-3940
1432-1920
language eng
recordid cdi_proquest_miscellaneous_2415291593
source SpringerLink Journals - AutoHoldings
subjects Blood vessels
Cardiovascular system
Imaging
Interventional Neuroradiology
Medicine
Medicine & Public Health
Neurology
Neuroradiology
Neurosciences
Neurosurgery
Radiology
title More than five stentriever passes: real benefit or futile recanalization?
url https://sfx.bib-bvb.de/sfx_tum?ctx_ver=Z39.88-2004&ctx_enc=info:ofi/enc:UTF-8&ctx_tim=2025-01-09T15%3A53%3A36IST&url_ver=Z39.88-2004&url_ctx_fmt=infofi/fmt:kev:mtx:ctx&rfr_id=info:sid/primo.exlibrisgroup.com:primo3-Article-proquest_cross&rft_val_fmt=info:ofi/fmt:kev:mtx:journal&rft.genre=article&rft.atitle=More%20than%20five%20stentriever%20passes:%20real%20benefit%20or%20futile%20recanalization?&rft.jtitle=Neuroradiology&rft.au=Filioglo,%20A.&rft.date=2020-10-01&rft.volume=62&rft.issue=10&rft.spage=1335&rft.epage=1340&rft.pages=1335-1340&rft.issn=0028-3940&rft.eissn=1432-1920&rft_id=info:doi/10.1007/s00234-020-02469-x&rft_dat=%3Cproquest_cross%3E2415291593%3C/proquest_cross%3E%3Curl%3E%3C/url%3E&disable_directlink=true&sfx.directlink=off&sfx.report_link=0&rft_id=info:oai/&rft_pqid=2440759946&rft_id=info:pmid/&rfr_iscdi=true